Literature DB >> 2828669

Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.

Y Hoshino1, L J Saif, M M Sereno, R M Chanock, A Z Kapikian.   

Abstract

A single-gene substitution reassortant 11-1 was generated from two porcine rotaviruses, OSU (serotype 5) and Gottfried (serotype 4). This reassortant derived 10 genes, including gene 4 encoding VP3, from the OSU strain and only gene 9, encoding a major neutralization glycoprotein (VP7), from the Gottfried strain and was thus designated VP3:5; VP7:4. Oral administration of this reassortant to colostrum-deprived gnotobiotic newborn pigs induced a high level of neutralizing antibodies not only to Gottfried VP7 but also to OSU VP3, thus demonstrating that VP3 is as potent an immunogen as VP7 in inducing neutralizing antibodies during experimental oral infection. Gnotobiotic piglets infected previously with the reassortant were completely resistant to oral challenge with the virulent Gottfried strain (VP3:4; VP7:4), as indicated by failure of symptoms to develop and lack of virus shedding. Similarly, prior infection with the reassortant induced almost complete protection against diarrhea and significant restriction of virus replication after oral challenge with the virulent OSU strain (VP3:5; VP7:5). Thus, it appears that (i) the immune system of the piglet responds equally well to two rotavirus outer capsid proteins, VP3 and VP7, during primary enteric rotavirus infection; (ii) antibody to VP3 and antibody to VP7 are each associated with resistance to diarrhea; and (iii) infection with a reassortant rotavirus bearing VP3 and VP7 neutralization antigens derived from two viruses of different serotype induces immunity to both parental viruses. The relevance of these findings to the development of effective reassortant rotavirus vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828669      PMCID: PMC253627          DOI: 10.1128/JVI.62.3.744-748.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination.

Authors:  A Z Kapikian; J Flores; Y Hoshino; R I Glass; K Midthun; M Gorziglia; R M Chanock
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

Review 2.  The relative importance of enteric pathogens affecting neonates of domestic animals.

Authors:  S Tzipori
Journal:  Adv Vet Sci Comp Med       Date:  1985

3.  Porcine pararotavirus: detection, differentiation from rotavirus, and pathogenesis in gnotobiotic pigs.

Authors:  E H Bohl; L J Saif; K W Theil; A G Agnes; R F Cross
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

4.  Use of transcription probes for genotyping rotavirus reassortants.

Authors:  J Flores; H B Greenberg; J Myslinski; A R Kalica; R G Wyatt; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

Review 5.  Rotaviruses: a review.

Authors:  M K Estes; E L Palmer; J F Obijeski
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

6.  Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes.

Authors:  R G Wyatt; H D James; A L Pittman; Y Hoshino; H B Greenberg; A R Kalica; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

7.  Virus-specific immunity in neonatal and adult mouse rotavirus infection.

Authors:  J F Sheridan; R S Eydelloth; S L Vonderfecht; L Aurelian
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Isolation and characterization of a canine rotavirus.

Authors:  Y Hoshino; R G Wyatt; F W Scott; M J Appel
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children.

Authors:  T Vesikari; E Isolauri; A Delem; E D'Hondt; F E André; G Zissis
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

10.  Gut mucosal immunization with reovirus serotype 1/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches.

Authors:  S D London; D H Rubin; J J Cebra
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  53 in total

1.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Evidence for two serotype G3 subtypes among equine rotaviruses.

Authors:  G F Browning; R M Chalmers; T A Fitzgerald; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses.

Authors:  D A Kool; S M Matsui; H B Greenberg; I H Holmes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant.

Authors:  M Gorziglia; A Z Kapikian
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23.

Authors:  G F Browning; T A Fitzgerald; R M Chalmers; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

8.  Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals.

Authors:  D R Snodgrass; T A Fitzgerald; I Campbell; G F Browning; F M Scott; Y Hoshino; R C Davies
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

9.  Serological characterization of bovine rotaviruses isolated from dairy and beef herds in Argentina.

Authors:  R C Bellinzoni; J O Blackhall; N M Mattion; M K Estes; D R Snodgrass; J L LaTorre; E A Scodeller
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

10.  VP4 monotype specificities among porcine rotavirus strains of the same VP4 serotype.

Authors:  F Liprandi; I Rodriguez; C Piña; G Larralde; M Gorziglia
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.